Introduction: Heart failure with reduced ejection fraction (HFrEF) causes high morbidity and mortality despite available therapies, indicating an unmet medical need. Activation of natriuretic peptide ...
The 29th annual Student Research and Community Engagement Symposium will be held at University Crossing on Tuesday, March 31. This university-wide competition is open to all UMass Lowell undergraduate ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO® ...
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to the principle that knowledge conquers cancer. Together with the Association for Clinical Oncology, ASCO ...
The Accepted Abstract Provides Supportive Evidence for the TAMP™ Therapy Platform’s Novel, Localized Approach to Targeted Chemotherapeutic Delivery via Additional Pharmacokinetic and Pharmacodynamic ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San ...
Free registration is available throughout the whole event and begins at 3:30pm. It is located at Snell Hall First Floor. There will be free refreshments. Click on the Title and Presenter(s) to read ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present a total of 14 abstracts with its research collaborators from multiple studies demonstrating the value of its ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present a total of 14 abstracts with its research collaborators from multiple studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results